Market Research Blog

The FMI analyst is of the opinion that market gains will further be upheld by the clinical benefits associated with use of vacuum mixing devices. FMI expects the vacuum mixing devices to see unwavering growth in the next 10 years, as the global healthcare space actively embraces ‘efficiency-enabling’ medical mixing equipment.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7515

Medical mixing processes have remained challenging for a long period of time, primarily undermined by the lack of competent technologies. With gradual evolution of vacuum mixing devices, a wide range of mixing applications are handled seamlessly in shorter timespan without compromising on the results.

According to the FMI report, the vacuum mixing devices market reflects a fair degree of fragmentation, wherein a large pool of regional manufacturers is competing neck to neck. Stryker Corporation and Zimmer Biomet remain two of the market goliaths, with strong product portfolios and extended regional presence.

A majority of the revenues of these two companies are generated from the US and Germany, and their focus on strategic collaborations will continue to yield significant profit benefits and ensure sustained growth. For instance, in 2018, Zimmer Biomet Holdings, Inc. – a global leader in musculoskeletal healthcare – collaborated with Apple to transform the patients’ journey for two most common type of surgeries undergone by the Americans every year – knee and hip replacement. This collaboration was aimed at popularizing the Zimmer Biomet ‘mymobility™’ app, an app that makes use of Apple Watch to facilitate constructive connections between patients and their respective surgical teams.

The FMI analyst finds that though the factors conditioning success differ for market players of varying statures, but in all the cases, the market partakers will have to be adept at effective tracking of the evolving market trends and make necessary adaptations.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-7515

Portability: The New Normal Grappling End User Appeal

In 2018, the devices with vertical orientation is estimated to surpass other variants and account for over ½ of the global vacuum mixing devices-derived value. Though end users will continue to invest in vertical vacuum mixing devices, the demand for rotational vacuum mixing devices will also see a considerable uptick through 2029, unveils FMI.

With ‘portable’ emerging as the new norm in the medical laboratory equipment space, manufacturers are jumping onto the ‘portability’ bandwagon by launching newer models of vacuum mixing devices that are easy-to-carry and compact in size. According to the FMI analysis, North America (29%) and Europe (26%) will continue to be the leading markets for vacuum mixing devices in 2019 and beyond, set in motion by robust healthcare infrastructure and massive investments in development of high-quality laboratory essentials.

Vacuum mixing devices worth ~ US$ 128 Mn were sold in hospitals in 2018, primarily driven by the growing number of inpatient and outpatient procedures. Manufacturers, to draw upon this increase in demand, are focusing on effective marketing of their products to hospitals by using ‘easy-to-use’ and ‘compatibility with varying viscosities’ as two of their key marketing touchpoints. However, various regulations put in place for manufacturing of vacuum mixing devices will continue to impede its penetration by increasing the ‘time-to-market’ factor.

While one-half of consumers investing in lip fillers look to boost their confidence levels, the other half will resort to these as quick fixes for facial perfection. Though lip augmentation wasn’t a mainstream concept a few decades ago, it is eventually carving out its own unique place in the global cosmetology space.

Millennials represent a very attractive category for lip filler manufacturers to focus on, given that the ones who are unhappy or self-conscious about their facial aesthetics are opting for these procedures to get appealing makeovers. The FMI analyst finds that a wide-range of safe and effective options will remain the key revenue level for companies active in the lip fillers market. In addition, these companies are also drawing upon the mega-trend of personalization via tailor-made lip filler solutions, which will further help them life their profit pools.

FMI’s research study opines that lip augmentation with hyaluronic acid-based solutions will remain the most frequently requested procedures in aesthetic practices. This can be gauged by the fact that in 2019, hyaluronic acid will surpass Poly-L-Lactic Acid to account of ~ 94% of the global lip fillers-derived business value.

While hospitals continue to remain at the forefront of demand for lip filler solutions, adoption by office based clinics is likely to pick pace by the end of 2029, thereby making it an attractive end user target for market players to aim at. Market players are zooming in their focus onto long-term contracts with hospitals and office based clinics, which will be a key factor ensuring continued profitability and long-term growth, finds the FMI report.

East Asia Promises Untapped Corners for the Market Players to Explore

The FMI analyst finds that North America continues to be the leading market for lip fillers, with the US estimated to command ~ 94.5% of the regional market growth. As per the recent studies, in 2018, nearly 18 million people underwent surgical and minimally-invasive cosmetic procedures in the United States in 2018. This is a clear indication of the fact cosmetic surgical procedures in North America, which are on a significant rise over the past 5-6 years, are further set for a massive growth in the future.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-10271

On the other hand, East Asia is emerging as the focal point for market players vying to make it big in the lip fillers market. With beauty standards seeing cyclical evolution in countries such as Japan, China, and South Korea, the East Asia lip fillers market is likely to promise some major expansion opportunities for the companies operating in the lip fillers market.

The FMI analyst is of the opinion that social media remains one of the biggest factors encouraging consumers to opt for lip fillers. With the selfie culture penetrating across consumer bases from different regions, lip fillers have become a highly feasible and readily accessible option for the consumers to get the ‘picture-ready’ appearance. However, potential risks associated with the use of lip fillers, including temporary bruises and permanent tissue spoilage, continue to daunt consumer confidence and, calling for safe and reliable variants to make their mark in the lip fillers market.

Increasing Research and Development Activities for Better Outcomes after Lip Procedures

Improvements in the preparation processes of lip fillers have led to a higher demand for lip procedures.

The development of advanced lip fillers with focus on stabilising the main ingredients and further cross-linking with the gel medium so as to prolong their effect are among the focus areas of manufacturers. Companies are also developing application-specific dermal fillers and expanding their product range to include fillers specific for lip augmentation, those that help increase the volume of the lips, etc.

Technological advancements leading to lip fillers will boost research activities and help boost the demand for modern injection techniques, which are also among factors expected to boost the lip fillers market.

However, manufacturers are hard pressed to innovate, as the applicability of highly advanced pulse oximeters extends beyond MRI environments.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-10020

Recent developments in medical devices allow for generation of real-time information, track past health records, identify potential issues, and devise effective treatment plans. FMI’s study finds that stakeholders in MRI pulse oximeters market are leveraging new sensor technologies, such as fiber optic SpO2 sensors to avoid conductive pathways, and improve device safety. With the approval of 7T MRI scanners, MRI pulse oximeters will further become the breeding ground for innovations and new developments.

A notable increase in the prevalence of chronic diseases has led to surge in the sales of high-end diagnostic machines, including those for MRI, and CT scanners, which in turn foster the demand for MRI pulse oximeters. Developed with non-magnetic components, MRI-compatible pulse oximeters have been gaining ground in early detection of critical congenital heart defects (CCHD) by accurately measuring the blood oxygen value of a newborn.

FMI study estimates that the MRI pulse oximeters market will register a CAGR of 2.4% during the given timeframe. High costs associated with MRI procedures have been creating a wave of reluctance among healthcare professionals and patients to adopt MRI pulse oximetry testing.

However, increasing popularity of medical tourism and favorable health insurance policies in both developed and developing countries are likely to attract patients towards expensive yet efficient MRI scan therapy, and subsequently drive the sales of MRI pulse oximeters.

MRI Pulse Oximeters – Extending the Traditional Functionality

The new-age medical technologies have transformed the way healthcare professionals and patients participate and interact with each other. Owing to rapid pace of technological advancements in healthcare industry, several medical devices have undergone a paradigm shift, and progressed significantly beyond their initial functions. In recent times, companies have been seeking to make their products stand out in an increasingly crowded market place, and some have invested heavily in design processes and capabilities.

Wireless MRI Pulse Oximeters Capture Significant Shares

Aligning with the rapid development of state-of-the-art medical devices and technologies, market players continue to increase the production of wireless MRI pulse oximeters that need not be connected to MRI machines. Operated through infrared (IR) or Bluetooth technology, wireless MRI pulse oximeters have also witnessed higher innovations and investments as compared to wired variants. As 6 in 10 units of MRI pulse oximeters sold in 2018 are wireless, manufacturers are specifically focused in this category. Additionally, MRI pulse oximeters without monitor continue to account for greater revenue share over their counterparts, as they can be coupled with a wide range of monitors.

According to the study, while business growth strategies remained influenced by the increasing adoption of MRI pulse oximeters in hospitals, manufacturers are working towards capitalizing on diagnostic laboratories and ambulatory surgical centers for expanded customer base. Increasing patient visits in well-equipped laboratories for complete diagnosis of diseases has also led to realignment of these strategies.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-10020

Growth prospects of the MRI pulse oximeters market, as identified by the FMI study, are high in North America. Heavy investments in R&D activities on medical devices and technologies along with favorable reimbursement scenario in the region are likely to offer lucrative opportunities for the market players. In addition, manufacturers are viewing Asia Pacific from target market perspective, considering increasing healthcare expenditure and growing awareness of new medical devices in the region.

The new business intelligence also offers key insights on the competitive scenario in the MRI pulse oximeters market. As per the study, the market shows a high level of consolidation, with top two players including Nonin and Koninklijke Philips N.V. collectively accounting for ~41% revenue share. Filling gaps in their portfolio to master the diagnosis of chronic diseases, rather than focusing solely on one specific product category will be key focus area for the stakeholders.

With growing need to understand and characterize microbial diversity, including that associated with human body, governments as well as private companies are increasingly investing in life science projects, thereby creating a greater demand for nucleic acid isolation and purification. While the high cost challenge persists, shortage of skilled professionals in healthcare and biopharma industries remain the longstanding challenges.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-10035

“Rapid and efficient methods or products to extract genomic RNA and DNA from virtually any biological sample have been growing in demand to ensure the success of downstream applications in molecular biology. With growing research on detection of tumor specific changes, FMI study finds that nucleic acid isolation and purification market vendors are exploring new technologies to facilitate ease-of-use and minimize user-error of their products.”

Future market Insights’ study reveals that the nucleic acid isolation and purification market is likely to expand at a CAGR of ~5% during the period 2019-2029. One of the key influencing factors is manufacturers’ focus to direct their investments towards advanced technologies such as magnetic-bead or bead-beating technology, to align with end users’ demand for an effective system for extraction of high-quality starting material and efficient inhibitor removal. The unique challenges for extracting and purifying nucleic acid from different organisms and tissue types, have also brought more focus on customized systems and solutions.

Advances in Microbiome Research to Dictate Manufacturers’ Growth Strategies

In comparison with RNA isolation kits, manufacturers continue to increase innovations and production of DNA isolation kits, as the category is expected to account for larger share in the market during the forecast period. As per the study, lucrative opportunities are identified in increasing application scope of DNA isolation and purification kits in various academic research institutes, contract research organizations, and biotechnologies companies to not only successfully extract the DNA but also to minimize the presence of contaminants and prevent nucleic acid degradation during preparation. As genomic and microbiome research advances, manufacturers are working on automating the nucleic acid isolation and purifications kits to recover DNA and RNA from the toughest samples used in microbiome work such as soil and stool samples.

Growth prospects of the nucleic acid isolation and purification market, as the study opines, are relatively high in developed countries of North America and Europe. Hefty investments in R&D on molecular biology and precision medicines over gradual increase in the prevalence of cancer, genetic disorders, and complex diseases are likely to influence the manufacturers to enhance their production capabilities.

Tapping into opportunities in China and Japan for acquiring local players and increasing manufacturing facilities will provide the added advantage to gain a new customer base. As innovations zoom in, a number of market players are working on offering products that are free of toxic organic solvents and enable cost-effective method to extract and purify PCR-ready DNA or RT-PCR-ready RNA from numerous samples.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-10035

The report also offers an incisive outlook on the competitive landscape of nucleic acid isolation and purification market. As per the study, extensive M&A activities and new launches remain the key focus areas of the market players. In addition, they are emphasizing on strengthening outsourcing and solutions through strategic collaborations.

The Broader Perspective

While the use of nucleic acid isolation and purification kits remained confined in academic research, demand from contract research organizations and biotechnology companies is gathering pace in the recent years. With growing need for separation and purification of nucleic moieties in studying diseases associated with various pathogens at genetic level, manufacturers are targeted towards automating sample purification, while reducing hands-on time and maintaining the top performance for downstream analysis.